NEW YORK (GenomeWeb) – Twist Bioscience today announced that it has secured a loan facility of up to $10 million with Silicon Valley Bank.

The San Francisco-based synthetic DNA manufacturer said that it can draw upon an unspecified portion of the loan immediately, while the remainder of the funds will be available upon the completion of certain milestones.

"This new loan facility provides flexibility within our business model to pursue strategic opportunities while maintaining our focus on product development," Twist Bio CEO Emily Leproust said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.